Cite

HARVARD Citation

    Yang, J. et al. (2022). Dupilumab combined with low‐dose systemic steroid therapy improves efficacy and safety for bullous pemphigoid. Dermatologic therapy. 35 (8), p. n/a. [Online]. 
  
Back to record